ABB071 - HY-P991956
Catalog #
HY-P991956
ABB071 is a humanized anti-CD180 monoclonal antibody. ABB071 can down-regulate the highly expressed TLR7 and IRF5 genes in systemic lupus erythematosus and induce the expression of PNPT1 and DNASE1L3 genes. ABB071 can inhibit the expression of genes related to the type I interferon pathway as well as interferon-stimulated genes (ISGs). ABB071 has anti-inflammatory activity and can reduce the levels of inflammatory cytokines. ABB071 can be used for research on systemic lupus erythematosus and psoriasis[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P991956/ABB071-DataSheet-MedChemExpress.pdf |
|---|---|
| Quantity | Get quote |
| Shipping | Room temperature |
| Application | COVID-19-immunoregulation |
| MWT | N/A |
| Clinical Information | No Development Reported |
| Target | Toll-like Receptor (TLR);Transmembrane Glycoprotein |
| Application: | COVID-19-immunoregulation |
|---|